The University of Warwick Library - WebBridge

ARTemis: A randomised trial of bevacizumab with neoadjuvant chemotherapy (NACT) for patients with HER2-negative early breast cancer-Primary endpoint, pathological complete response (pCR)
Earl, H. M..  Journal of Clinical Oncology.  v. 32. no. 15.   2014-05-20. p. 1014 - 1014... issn: 0732-183X .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.